Crinetics Pharmaceuticals
CRNX
CRNX
63 hedge funds and large institutions have $473M invested in Crinetics Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4.82% more ownership
Funds ownership: 73.6% → 78.42% (+4.8%)
2% more funds holding
Funds holding: 62 → 63 (+1)
Holders
63
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$10.5M | |
| 2 | +$5M | |
| 3 | +$4.17M | |
| 4 |
BlackRock
New York
|
+$3.86M |
| 5 |
O
OrbiMed
New York
|
+$3.12M |
Top Sellers
| 1 | -$4.55M | |
| 2 | -$2.21M | |
| 3 | -$1.06M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$925K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$434K |